Wang Wang Wang
commented on
Perfectly competitive firms earn zero economic profits is a classical conclusion in economics. The reason is simple: when many firms produce the same products in the same market, price wars are likely inevitable until prices are driven down to cost levels. Thus, to avoid price wars or, in other words, to gain pricing power, companies need to find ways to build a moat that protects them from competitors, such as developing unique ...
40
87
Wang Wang Wang
reacted to
US Consumer Spending Slows
$Disney (DIS.US)$ reported better-than-expected earnings and revenue for the June quarter on Wednesday, with its streaming service turning a profit for the first time. The company also raised its full-year profit guidance. Despite positive results, shares fell over 4% due to ongoing concerns about its theme park business.
Revenue from U.S. and Canadian parks dropped 6% year-over-year to $1.35 billion, while internatio...
$Disney (DIS.US)$ reported better-than-expected earnings and revenue for the June quarter on Wednesday, with its streaming service turning a profit for the first time. The company also raised its full-year profit guidance. Despite positive results, shares fell over 4% due to ongoing concerns about its theme park business.
Revenue from U.S. and Canadian parks dropped 6% year-over-year to $1.35 billion, while internatio...
40
7
Wang Wang Wang
liked
Not asking for advice. I may have to admit defeat after knowing that there is a compound decay in this ticker.
No is not that I got scammed into the stock. It is a misunderstanding that got me into the stock.
Till then all I can do now is grief and wait for a rebound. 🤞
Monday may not sound rosy either as there is a risk of a selldown from Buffett's sale of $Apple (AAPL.US)$ weeks ago.
When the news comes out it is to make a play for retailers to sell more....
No is not that I got scammed into the stock. It is a misunderstanding that got me into the stock.
Till then all I can do now is grief and wait for a rebound. 🤞
Monday may not sound rosy either as there is a risk of a selldown from Buffett's sale of $Apple (AAPL.US)$ weeks ago.
When the news comes out it is to make a play for retailers to sell more....
19
21
Wang Wang Wang
Set a live reminder
$Palantir (PLTR.US)$
Palantir Q2 2024 earnings conference call is scheduled for August 5 at 5:00 PM ET /August 6 at 5:00 AM SGT /August 6 at 7:00 AM AEST. Subscribe to join the live earnings conference with management NOW!
Beat or Miss?
What do you expect from Palantir's Q2 earnings? Will the company beat or miss the estimates? Make sure to click the "Book" button to get what managements have to say!
Disclaimer:
This presentation is for information and e...
Palantir Q2 2024 earnings conference call is scheduled for August 5 at 5:00 PM ET /August 6 at 5:00 AM SGT /August 6 at 7:00 AM AEST. Subscribe to join the live earnings conference with management NOW!
Beat or Miss?
What do you expect from Palantir's Q2 earnings? Will the company beat or miss the estimates? Make sure to click the "Book" button to get what managements have to say!
Disclaimer:
This presentation is for information and e...
Palantir Q2 2024 earnings conference call
Aug 5 16:00
7
Wang Wang Wang
liked
$Apple (AAPL.US)$ very lousy institutions play.... all estimates heated but no movement on the stock....us market kind of soft now and need Viagra...
3
Wang Wang Wang
voted
Hi, mooers!
Just a heads-up:
Earnings Challenge is in full swing! What's your take on Palantir's earnings and its stock performance? Now join the challenge, leverage moomoo's handy features to support your views on Palantir and earn plenty of rewards! Don't miss the chance to win big>>
$Palantir (PLTR.US)$ is releasing its Q2 earnings on August 5 after the bell. Unlock insights with Palantir Earnings Hub>>
For the details o...
Just a heads-up:
Earnings Challenge is in full swing! What's your take on Palantir's earnings and its stock performance? Now join the challenge, leverage moomoo's handy features to support your views on Palantir and earn plenty of rewards! Don't miss the chance to win big>>
$Palantir (PLTR.US)$ is releasing its Q2 earnings on August 5 after the bell. Unlock insights with Palantir Earnings Hub>>
For the details o...
78
120
Wang Wang Wang
voted
$Apple (AAPL.US)$ investors flocked to call options giving the holders the right to buy the stock at $250 in contracts stretching through December 2026, signaling optimism over longer-term outlook of the iPhone maker.
The $250 call options have a combined open interest of more than 296,000, the biggest tally of all outstanding Apple contracts for any strike price, including puts, data compiled by moomoo showed. The...
The $250 call options have a combined open interest of more than 296,000, the biggest tally of all outstanding Apple contracts for any strike price, including puts, data compiled by moomoo showed. The...
+1
23
2
Wang Wang Wang
liked
$Vertiv Holdings (VRT.US)$ damn it. Good result yet sinking.
3
1
Wang Wang Wang
liked and commented on
Let us know which stocks you want Isaac to analyse LIVE on Trader’s Talk: https://docs.google.com/forms/d/1G58enfa28FOHbS0_8Ozn78dBdNPTMj8WqIlRtVR0CxQ/edit
TGIF Moo-ers! As we enter into the weekend, it’s time to take stock of what has been a whirlwind week. From the ‘Trump Trade’ to a rotation out of tech to a selloff in the three major US stock indexes, concerns appear to be growing around the longevity of the current bull market run.
The CBOE Market Volatility I...
TGIF Moo-ers! As we enter into the weekend, it’s time to take stock of what has been a whirlwind week. From the ‘Trump Trade’ to a rotation out of tech to a selloff in the three major US stock indexes, concerns appear to be growing around the longevity of the current bull market run.
The CBOE Market Volatility I...
Buy the dip, or clear the ship?
Jul 22 22:00
131
35
Wang Wang Wang : Company A is Eli Lilly and Company. Company B is Novo Nordisk. Company C is Pfizer.
Pfizer's stock has performed the worst in the last two years. Specifically, Pfizer's stock has struggled due to:
Decline in COVID-19 Vaccine Revenue: Pfizer's significant revenue boost from its COVID-19 vaccine, Comirnaty, has decreased as global vaccination rates stabilize and new variants of the virus emerge less frequently.
Patent Expirations: Pfizer faced the loss of exclusivity on several key drugs, leading to increased competition from generic and biosimilar products.
Slower Pipeline Growth: The company has faced challenges in bringing new blockbuster drugs to market at the pace needed to offset declines in revenue from older medications.
These factors combined have led to a weaker stock performance relative to competitors like Eli Lilly and Novo Nordisk.